RECK antibody (AA 801-900) (FITC)
Quick Overview for RECK antibody (AA 801-900) (FITC) (ABIN681425)
Target
See all RECK AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 801-900
-
Purpose
- RECK Polyclonal Antibody, FITC Conjugated
-
Cross-Reactivity
- Human, Mouse
-
Predicted Reactivity
- Rat,Dog,Cow,Sheep,Pig,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human RECK
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB(1:300-5000), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- RECK (Reversion-Inducing-Cysteine-Rich Protein with Kazal Motifs (RECK))
-
Alternative Name
- RECK
-
Background
-
Synonyms: ST15, Reversion-inducing cysteine-rich protein with Kazal motifs, hRECK, Suppressor of tumorigenicity 15 protein, RECK
Background: Negatively regulates matrix metalloproteinase-9 (MMP-9) by suppressing MMP-9 secretion and by direct inhibition of its enzymatic activity. RECK down-regulation by oncogenic signals may facilitate tumor invasion and metastasis. Appears to also regulate MMP-2 and MT1-MMP, which are involved in cancer progression.
-
Gene ID
- 8434
-
UniProt
- O95980
Target
-